Max Cigrang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Dna Damage Response

Basal Cell Carcinoma

Gene Expression

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jérémy Sandoz, Max Cigrang, Amélie Zachayus, Philippe Catez, Lise-Marie Donnio, Clèmence Elly, Jadwiga Nieminuszczy, Pietro Berico, Cathy Braun, Sergey Alekseev, Jean-Marc Egly, Wojciech Niedzwiedz, Giuseppina Giglia-Mari, Emmanuel Compe, Frederic Coin
Active mRNA degradation by EXD2 nuclease elicits recovery of transcription after genotoxic stress. Nature communications 14 (1) (2023)
Jérémy Sandoz, Max Cigrang, Amélie Zachayus, Philippe Catez, Lise-Marie Donnio, Clèmence Elly, Jadwiga Nieminuszczy, Pietro Berico, Cathy Braun, Sergey Alekseev, Jean-Marc Egly, Wojciech Niedzwiedz, Giuseppina Giglia-Mari, Emmanuel Compe, Frederic Coin
Active mRNA degradation by EXD2 nuclease elicits recovery of transcription after genotoxic stress. Nature communications 14 (1) (2023)
Jérémy Sandoz, Max Cigrang, Amélie Zachayus, Philippe Catez, Lise-Marie Donnio, Clèmence Elly, Jadwiga Nieminuszczy, Pietro Berico, Cathy Braun, Sergey Alekseev, Jean-Marc Egly, Wojciech Niedzwiedz, Giuseppina Giglia-Mari, Emmanuel Compe, Frederic Coin
Active mRNA degradation by EXD2 nuclease elicits recovery of transcription after genotoxic stress. Nature communications 14 (1) (2023)
Pietro Berico, Max Cigrang, Guillaume Davidson, Cathy Braun, Jeremy Sandoz, Stephanie Legras, Bujamin Hektor Vokshi, Nevena Slovic, François Peyresaubes, Carlos Mario Gene Robles, Jean Marc Egly, Emmanuel Compe, Irwin Davidson, Frederic Coin
CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma. EMBO reports 22 (9) (2021)